IRC
HOOK

Investors Research Corp’s HOOKIPA Pharma HOOK Stock Holding History

Investors Research Corp’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8
Closed -$65 – 1141
2022
Q4 		$65 Hold
8
– – ﹤0.01% 1124
2022
Q3 		$0 Hold
8
– – ﹤0.01% 1109
2022
Q2 		$0 Hold
8
– – ﹤0.01% 1109
2022
Q1 		$0 Hold
8
– – ﹤0.01% 1053
2021
Q4 		$0 Hold
8
– – ﹤0.01% 1014
2021
Q3 		$0 Hold
8
– – ﹤0.01% 1010
2021
Q2 		$1K Hold
8
– – ﹤0.01% 937
2021
Q1 		$1K Hold
8
– – ﹤0.01% 931
2020
Q4 		$1K Hold
8
– – ﹤0.01% 1030
2020
Q3 		$1K Buy
+8
New +$816 ﹤0.01% 1043

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Investors Research Corp's HOOK Position: Q1 2023 in Review

Investors Research Corp sold out of HOOKIPA Pharma (HOOK) in Q1 2023, closing a stake of 8 shares — an estimated $65 sold.

Investors Research Corp first reported a position in HOOK in Q3 2020 and held it in 10 quarters. The position peaked at $1K in Q2 2021. 45 funds tracked by Wall St. Rank hold HOOK as of Q1 2023.

  • Investors Research Corp reported no remaining HOOKIPA Pharma position as of Q1 2023 after selling out during the quarter.
  • Investors Research Corp sold 8 HOOKIPA Pharma shares in Q1 2023, an estimated $65.
  • Investors Research Corp first reported a position in HOOKIPA Pharma in Q3 2020 and held it in 10 quarters.
  • Investors Research Corp's HOOKIPA Pharma position peaked at $1K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2023.

Based on Investors Research Corp's 13F filing for Q1 2023, filed 11 May 2023.